Lamivudine-galactose

• CAT Number: I007328
• CAS Number: N/A
• Purity: ≥95%
• Synonyms: Lamivudine-galactose;4-amino-1-((2R,5S)-2-((((2R,3R,4S,5R,6S)-3,4,5,6-tetrahydroxytetrahydro-2H-pyran-2-yl)methoxy)methyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one
• Solubility: Soluble in DMSO, not in water
• Storage: 0 - 4°C for short term , or -20°C for long term.

Lamivudine-galactose（Cat No.:I007328）is a conjugate of lamivudine, an antiviral medication, and galactose, a sugar molecule. Lamivudine is commonly used to treat chronic hepatitis B and HIV infections by inhibiting viral reverse transcriptase, a key enzyme required for viral replication. The addition of galactose to lamivudine is intended to enhance the targeting of the drug to liver cells, where hepatitis B primarily affects. This conjugation may improve the pharmacokinetics and therapeutic efficacy of lamivudine in liver-targeted drug delivery, potentially offering better treatment outcomes in hepatitis and related liver conditions.